How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

170 results for

Emergency Pediatric Dosing 19-22 kilogram

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Emergency Pediatric Dosing 19-22 kilogram

Emergency Pediatric Dosing 19-22 kilogram Emergency Pediatric Dosing 19-22 kilogram Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Emergency Pediatric Dosing 19-22 kilogram Emergency Pediatric Dosing 19-22 kilogram Aka: Emergency Pediatric Dosing 19-22 kilogram , Broselow Blue II. Criteria: Body habitus Age: 5-6 years Length: 110 to 122 cm Weight: 19-22 kg (mean 21 kg) III. Findings: Vital Signs (normal) : 65-135/minute : 20-30/minute Systolic : 80-110 mmHg IV. Medications: Rapid Sequence Intubation (RSI) and intubation and ventilation Induction (Sedation) 6.3 mg 42 mg 63 mg Paralytic 40 mg 21 mg 2.1 mg Sedation Maintenance 1 mg

2018 FP Notebook

2. Emergency Pediatric Dosing 15-18 kilogram

Emergency Pediatric Dosing 15-18 kilogram Emergency Pediatric Dosing 15-18 kilogram Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Emergency Pediatric Dosing 15-18 kilogram Emergency Pediatric Dosing 15-18 kilogram Aka: Emergency Pediatric Dosing 15-18 kilogram , Broselow White II. Criteria: Body habitus Age: 3-4 years Length: 97.5 to 110 cm Weight: 15-18 kg (mean 16.5 kg) III. Findings: Vital Signs (normal) : 75-135/minute : 20-30/minute Systolic : 80-110 mmHg IV. Medications: Rapid Sequence Intubation (RSI) and intubation and ventilation Induction (Sedation) 5 mg 33 mg 50 mg Paralytic 33 mg 17 mg 1.7 mg Sedation Maintenance 0.8

2018 FP Notebook

3. Emergency Pediatric Dosing 19-22 kilogram

Emergency Pediatric Dosing 19-22 kilogram Emergency Pediatric Dosing 19-22 kilogram Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Emergency Pediatric Dosing 19-22 kilogram Emergency Pediatric Dosing 19-22 kilogram Aka: Emergency Pediatric Dosing 19-22 kilogram , Broselow Blue II. Criteria: Body habitus Age: 5-6 years Length: 110 to 122 cm Weight: 19-22 kg (mean 21 kg) III. Findings: Vital Signs (normal) : 65-135/minute : 20-30/minute Systolic : 80-110 mmHg IV. Medications: Rapid Sequence Intubation (RSI) and intubation and ventilation Induction (Sedation) 6.3 mg 42 mg 63 mg Paralytic 40 mg 21 mg 2.1 mg Sedation Maintenance 1 mg

2015 FP Notebook

4. Emergency Pediatric Dosing 15-18 kilogram

Emergency Pediatric Dosing 15-18 kilogram Emergency Pediatric Dosing 15-18 kilogram Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Emergency Pediatric Dosing 15-18 kilogram Emergency Pediatric Dosing 15-18 kilogram Aka: Emergency Pediatric Dosing 15-18 kilogram , Broselow White II. Criteria: Body habitus Age: 3-4 years Length: 97.5 to 110 cm Weight: 15-18 kg (mean 16.5 kg) III. Findings: Vital Signs (normal) : 75-135/minute : 20-30/minute Systolic : 80-110 mmHg IV. Medications: Rapid Sequence Intubation (RSI) and intubation and ventilation Induction (Sedation) 5 mg 33 mg 50 mg Paralytic 33 mg 17 mg 1.7 mg Sedation Maintenance 0.8

2015 FP Notebook

5. Principles of Pediatric Patient Safety: Reducing Harm Due to Medical Care

of or method of using a treatment, 11% involved patient misidentification, and 7% involved delays or errors in diagnosis. , , Pediatric errors in emergency department (ED) settings may be attributable to multiple factors, including incorrect patient identification, lack of experience of many ED staff with pediatric patients versus with adults, and challenges with performing technical procedures in and calculating medication doses for children. , Other sources of error include communication between (...) adverse drug events. The preventive strategies with the most potential to reduce errors were determined to be improved communication between providers and parents and between pharmacists and parents. Among new prescriptions for 22 common medications in outpatient pediatric clinics, 15% were issued with potential dosing errors. In addition, drug samples are often dispensed with inadequate documentation. Children with special health care needs have been reported to be at higher risk for medication

2019 American Academy of Pediatrics

6. The economic evaluation of early intervention with Anti-Tumor Necrosis Factor-alpha treatments in pediatric Crohn's disease

Incremental cost-utility ratio IFX Infliximab IM Immunomodulator ISPOR International Society For Pharmacoeconomics and Outcomes Research MOHLTC Ontario Ministry of Health and Long-Term Care kcal Calorie kg Kilogram mg Milligram MTA Material transfer agreement MTX Methotrexate NICE National Institute for Health and Care Excellence (United Kingdom) OCCI Ontario Case Costing Initiative OR Odds ratio PCDAI Pediatric Crohn’s Disease Activity Index PGA Physician Global Assessment QALY Quality-adjusted life year (...) 6 1.3 Anti-TNF-a Interventions and How They Might Work 7 1.4 Clinical Efficacy of Anti-TNF-a Treatments in Pediatric Crohn’s Disease 8 1.4.1 Studies and Reviews of the Clinical Efficacy of Anti-TNF-a Treatments 8 1.5 Economic Evaluations and Health Technology Assessments of Anti-TNF-a Treatments in Crohn’s Disease 13 1.6 Treatment Pathway in Crohn’s Disease 18 1.7 Theoretical Framework 19 1.8 The Problem 23 1.9 Primary Objective 23 1.10 Secondary Objective 24 1.11 Research Design 25 Methods 27

2019 SickKids Reports

7. Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock

, MI. 19 Departments of Pediatrics and Biochemistry, Washington University in Saint Louis School of Medicine, Saint Louis, MO. 20 Department of Pediatrics, Centre mère-enfant Soleil du CHU de Québec-Université Laval, Québec City, QC, Canada. 21 Department of Inpatient Pediatrics, Kaiser Santa Clara Medical Center, Santa Clara, CA. 22 Department of Anesthesiology and Critical Care Medicine, University of Pennsylvania Perelman School of Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA (...) . 10 Department of Pediatrics, Baylor College of Medicine, Houston, TX. 11 Department of Pediatrics, Saint Barnabas Medical Center, Livingston, NJ. 12 Division of Emergency Medicine and Center for Pediatric Clinical Effectiveness, University of Pennsylvania Perelman School of Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA. 13 Intensive Care & Bioethics, Great Ormond St Hospital for Sick Children, London, United Kingdom. 14 Pediatric Critical Care Medicine, Department of Pediatrics

2017 Society of Critical Care Medicine

8. Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures

and anxiolysis, the need for sedation for procedures in physicians’ offices, dental offices, subspecialty procedure suites, imaging facilities, emergency departments, other inpatient hospital settings, and ambulatory surgery centers also has increased markedly. 1–52 In recognition of this need for both elective and emergency use of sedation in nontraditional settings, the American Academy of Pediatrics (AAP) and the American Academy of Pediatric Dentistry (AAPD) have published a series of guidelines (...) /electroence- phalography. EMS: Emergency medical services. LMA: Laryngeal mask airway. MRI: Magnetic resonance imaging. OSA: Obstructive sleep apnea. PALS: Pediatric advanced life support. Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures: Update 2016 Developed and Endorsed by American Academy of Pediatric Dentistry and American Academy of Pediatrics Latest Revision* 2016 * This guideline was originally adopted in 2006

2016 American Academy of Pediatric Dentistry

9. Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management

Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses (...) cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management A Scientific Statement From the American Heart Association , MD, MS , MD , MD , MD, FAHA , MD, FAHA , MD , MD, FAHA , MD, FAHA , MD , MD , MD , MD , MD , MD , and RN, FAHA PhDon behalf of the American Heart Association Heart Failure and Transplantation Committee

2015 American Heart Association

10. A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation

(Open Label) Primary Purpose: Treatment Official Title: A Randomized, Open Label, 2-Period, 2-Treatment, Cross-over Phase 1 Study to Evaluate the Bio-equivalence of Single Oral Dose of TAK-536 Pediatric Formulation and TAK-536 Commercial Formulation in Healthy Adult Male Subjects Actual Study Start Date : February 10, 2017 Actual Primary Completion Date : March 11, 2017 Actual Study Completion Date : March 11, 2017 Resource links provided by the National Library of Medicine available for: Arms (...) Time 0 to Infinity for TAK-536 [ Time Frame: Day 1 pre-dose and at multiple time points post-dose (0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 12, 16, 24, and 48 hours post-dose; up to 48 hours) ] Terminal Disposition Phase Rate Constant (λz) for TAK-536 [ Time Frame: Day 1 pre-dose and at multiple time points post-dose (0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 12, 16, 24, and 48 hours post-dose; up to 48 hours) ] Number of Participants Reporting One or More Treatment-emergent Adverse Events (TEAEs

2017 Clinical Trials

11. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

participating. Read our for details. ClinicalTrials.gov Identifier: NCT03196427 Recruitment Status : Recruiting First Posted : June 22, 2017 Last Update Posted : October 9, 2018 See Sponsor: Takeda Information provided by (Responsible Party): Takeda Study Details Study Description Go to Brief Summary: The purpose of this study is to determine the safety profile of long-term vedolizumab IV treatment in pediatric participants with UC or CD. Condition or disease Intervention/treatment Phase Ulcerative Colitis (...) to Arm Intervention/treatment Experimental: Vedolizumab High Dose Group Participants with UC or CD having baseline weight of greater than or equal to (>=) 30 kilogram (kg) will receive Vedolizumab 300 milligram (mg) and participants with UC or CD having baseline weight of less than (<) 30 kg will receive Vedolizumab 200 mg, intravenous infusion, every 8 weeks for up to 5 years. Drug: Vedolizumab Vedolizumab intravenous infusion. Other Names: MLN0002 ENTYVIO KYNTELES Experimental: Vedolizumab Low Dose

2017 Clinical Trials

12. Pediatric Supraventricular Tachycardia

features, response to treatment, and long-term follow-up in 217 patients. J Pediatr. 1981;98(6):875-82. Kugler JD, Danford DA. Management of infants, children, and adolescents with paroxysmal supraventricular tachycardia. J Pediatr. 1996;129(3):324-38. Spencer B, Chacko J, Sallee D. The 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiac care: an overview of the changes to pediatric basic and advanced life support. Crit Care Nurs Clin North Am. 2011;23(2 (...) ):303-10. By | 2016-12-14T12:56:45-04:00 September 15th, 2015 | | Share this post About the Author: Brad Sobolewski, MD, MEd is an Associate Professor of Pediatric Emergency Medicine and an Assistant Director for the Pediatric Residency Training Program at Cincinnati Children's Hospital Medical Center. He is on Twitter @PEMTweets and authors the Pediatric Emergency Medicine site PEMBlog. All views are strictly my own and not official medical advice. Related Posts March 12th, 2019 | May 15th, 2018

2015 PEM Blog

13. Emergency Procedural Sedation With Propofol in Older Teenagers: Any Cause for Concern? (PubMed)

Emergency Procedural Sedation With Propofol in Older Teenagers: Any Cause for Concern? Propofol is a standard for adult emergency department procedural sedation (EDPS). Use in pediatric patients remains controversial. Our primary objective was to investigate whether adverse events occurred more frequently in teenage pediatric patients receiving propofol for EDPS.This retrospective study examines records from the Halifax Procedural Sedation Registry, collected between January 1, 2006 and May 31 (...) confirmed on multivariate analysis. Patients in the teenage group received higher doses of propofol per kilogram/minute than the other groups. No other differences met statistical significance.Teenage patients receiving EDPS with propofol had a lower incidence of adverse events, and both received and tolerated larger adjusted doses of medication than older patients. Satisfaction and duration of EDPS were similar. Concerns about propofol use in younger patients have not been supported by this study. We

2015 Pediatric Emergency Care

14. Pediatrics, Dehydration (Treatment)

=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvODAxMDEyLXRyZWF0bWVudA== processing > Pediatric Dehydration Treatment & Management Updated: Nov 12, 2018 Author: Alex Koyfman, MD; Chief Editor: Muhammad Waseem, MBBS, MS, FAAP, FACEP, FAHA Share Email Print Feedback Close Sections Sections Pediatric Dehydration Treatment Approach Considerations Address emergent airway, breathing, and circulatory problems first. Obtain intravenous access, and give a 20 mL/kg isotonic fluid bolus (Ringer lactate or normal saline) to children with severe volume depletion. This should (...) dose is 0.25 g/kg IV (2.5 mL/kg of 10% dextrose or 1 mL/kg of 25% dextrose) with reassessment of glucose level after administration of dextrose. Once vital sign abnormalities are corrected, initiate maintenance fluid therapy plus additional fluid to make up for any continued losses. Daily requirements for maintenance fluids can be approximated as follows: If the patient weighs less than 10 kg, give 100 mL/kg/d If the patient weighs less than 20 kg, give 1000 mL/d plus 50 mL/kg/d for each kilogram

2014 eMedicine Emergency Medicine

15. Pediatrics, Diabetic Ketoacidosis (Treatment)

Pediatrics, Diabetic Ketoacidosis (Treatment) Pediatric Diabetic Ketoacidosis Emergency Department Care Treatment & Management: Prehospital Care, Emergency Department Care, Consultations Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache (...) =aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvODAxMTE3LXRyZWF0bWVudA== processing > Pediatric Diabetic Ketoacidosis Emergency Department Care Treatment & Management Updated: May 21, 2018 Author: Grace M Young, MD; Chief Editor: Sasigarn A Bowden, MD Share Email Print Feedback Close Sections Sections Pediatric Diabetic Ketoacidosis Emergency Department Care Treatment Prehospital Care Provide oxygen and advanced airway management in patients with diabetic ketoacidosis (DKA), if needed. [ ] Monitor the patient. Provide isotonic intravenous fluids (eg, isotonic

2014 eMedicine Emergency Medicine

16. Pediatrics, Sedation (Follow-up)

seconds). Its duration of action is 1-3 minutes, allowing swift emergence and recovery. Preliminary pediatric studies indicate that propofol is efficacious in terms of providing sedation and is easy to use. Monitored anesthesia care (MAC) sedation dosing is 0.5-1 mg/kg by IV push, infused over 2 minutes initially. Maintenance dosing is 0.5-1 mg/kg IV every 3-5 minutes as needed or, alternatively, 50-150 µg/kg/min by continuous IV infusion. Initially, propofol was used as an induction agent in general (...) Procedural Sedation for Children. JAMA Pediatr . 2017 Aug 21. . Di Francesco MW, Robertson SA, Karunanayaka P, Holland SK. BOLD fMRI in infants under sedation: Comparing the impact of pentobarbital and propofol on auditory and language activation. J Magn Reson Imaging . 2013 Mar 22. . Green SM. Krauss B. Barriers to Propofol Use in Emergency Medicine. Ann Emerg Med . 2008. 52:392-398. . Patel KN. Simon HK. Stockwell CA. Pediatric Procedural Sedation by a Dedicated Nonanesthesiology Pediatric Sedation

2014 eMedicine Emergency Medicine

17. Pediatrics, Sedation (Diagnosis)

seconds). Its duration of action is 1-3 minutes, allowing swift emergence and recovery. Preliminary pediatric studies indicate that propofol is efficacious in terms of providing sedation and is easy to use. Monitored anesthesia care (MAC) sedation dosing is 0.5-1 mg/kg by IV push, infused over 2 minutes initially. Maintenance dosing is 0.5-1 mg/kg IV every 3-5 minutes as needed or, alternatively, 50-150 µg/kg/min by continuous IV infusion. Initially, propofol was used as an induction agent in general (...) Procedural Sedation for Children. JAMA Pediatr . 2017 Aug 21. . Di Francesco MW, Robertson SA, Karunanayaka P, Holland SK. BOLD fMRI in infants under sedation: Comparing the impact of pentobarbital and propofol on auditory and language activation. J Magn Reson Imaging . 2013 Mar 22. . Green SM. Krauss B. Barriers to Propofol Use in Emergency Medicine. Ann Emerg Med . 2008. 52:392-398. . Patel KN. Simon HK. Stockwell CA. Pediatric Procedural Sedation by a Dedicated Nonanesthesiology Pediatric Sedation

2014 eMedicine Emergency Medicine

18. Pediatrics, Sedation (Treatment)

seconds). Its duration of action is 1-3 minutes, allowing swift emergence and recovery. Preliminary pediatric studies indicate that propofol is efficacious in terms of providing sedation and is easy to use. Monitored anesthesia care (MAC) sedation dosing is 0.5-1 mg/kg by IV push, infused over 2 minutes initially. Maintenance dosing is 0.5-1 mg/kg IV every 3-5 minutes as needed or, alternatively, 50-150 µg/kg/min by continuous IV infusion. Initially, propofol was used as an induction agent in general (...) Procedural Sedation for Children. JAMA Pediatr . 2017 Aug 21. . Di Francesco MW, Robertson SA, Karunanayaka P, Holland SK. BOLD fMRI in infants under sedation: Comparing the impact of pentobarbital and propofol on auditory and language activation. J Magn Reson Imaging . 2013 Mar 22. . Green SM. Krauss B. Barriers to Propofol Use in Emergency Medicine. Ann Emerg Med . 2008. 52:392-398. . Patel KN. Simon HK. Stockwell CA. Pediatric Procedural Sedation by a Dedicated Nonanesthesiology Pediatric Sedation

2014 eMedicine Emergency Medicine

19. Pediatrics, Sedation (Overview)

seconds). Its duration of action is 1-3 minutes, allowing swift emergence and recovery. Preliminary pediatric studies indicate that propofol is efficacious in terms of providing sedation and is easy to use. Monitored anesthesia care (MAC) sedation dosing is 0.5-1 mg/kg by IV push, infused over 2 minutes initially. Maintenance dosing is 0.5-1 mg/kg IV every 3-5 minutes as needed or, alternatively, 50-150 µg/kg/min by continuous IV infusion. Initially, propofol was used as an induction agent in general (...) Procedural Sedation for Children. JAMA Pediatr . 2017 Aug 21. . Di Francesco MW, Robertson SA, Karunanayaka P, Holland SK. BOLD fMRI in infants under sedation: Comparing the impact of pentobarbital and propofol on auditory and language activation. J Magn Reson Imaging . 2013 Mar 22. . Green SM. Krauss B. Barriers to Propofol Use in Emergency Medicine. Ann Emerg Med . 2008. 52:392-398. . Patel KN. Simon HK. Stockwell CA. Pediatric Procedural Sedation by a Dedicated Nonanesthesiology Pediatric Sedation

2014 eMedicine Emergency Medicine

20. Pediatrics, Diabetic Ketoacidosis (Follow-up)

Pediatrics, Diabetic Ketoacidosis (Follow-up) Pediatric Diabetic Ketoacidosis Emergency Department Care Treatment & Management: Prehospital Care, Emergency Department Care, Consultations Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache (...) =aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvODAxMTE3LXRyZWF0bWVudA== processing > Pediatric Diabetic Ketoacidosis Emergency Department Care Treatment & Management Updated: May 21, 2018 Author: Grace M Young, MD; Chief Editor: Sasigarn A Bowden, MD Share Email Print Feedback Close Sections Sections Pediatric Diabetic Ketoacidosis Emergency Department Care Treatment Prehospital Care Provide oxygen and advanced airway management in patients with diabetic ketoacidosis (DKA), if needed. [ ] Monitor the patient. Provide isotonic intravenous fluids (eg, isotonic

2014 eMedicine Emergency Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>